European Healthcare Expenditure on Over-The-Counter Medicines by Country

The European healthcare expenditure on over-the-counter (OTC) medicines varies significantly across countries. In 2024, the United Kingdom leads with a value of 10.19 billion euros, followed by Germany at 8.04 billion euros. Countries like Poland (3.88 billion), Spain (3.74 billion), and France (2.67 billion) have moderate expenditures compared to the leading nations. Meanwhile, countries such as Liechtenstein, Malta, and Iceland have the least expenditure, with values of 0.00448, 0.02217, and 0.04166 billion euros respectively.

Over the past two years, notable increases in OTC expenditure have been seen in Romania (+14.86%), Bosnia and Herzegovina (+10.19%), and the Czech Republic (+8.07%). In contrast, France and Croatia have experienced declines of -3.81% and -2.93% respectively. The compound annual growth rate (CAGR) over the last five years illustrates varying trends with some countries showing steady growth while others remain flat or decline slightly.

Future trends to watch include the continuation of high growth rates in emerging markets like Romania and Bosnia and Herzegovina, potential stabilization in major markets such as the UK and Germany, and the impact of digital health solutions and e-commerce on OTC medicine sales.